Who
Michael Joseph Driscoll
Director
Company insider
Files Form 4 as: Director, Organogenesis Holdings.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 1
- Bought
- $77K
- Sold
- $128K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Feb 2022
- Last trade
- 9 Mar 2026
- Last filed
- 11 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Mar 2026filed 11 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Bought | $27K10,000 at $2.67 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Bought | $27K10,000 at $2.67 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,828 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —48,828 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Sold | $128K25,000 at $5.10 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —49,575 at $0.00 | filing |
| 21 Feb 2024filed 23 Feb 2024 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —51,020 at $0.00 | filing |
| 22 Feb 2023filed 24 Feb 2023 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —65,737 at $0.00 | filing |
| 12 Aug 2022filed 15 Aug 2022 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Bought | $24K5,000 at $4.80 | filing |
| 15 Feb 2022filed 17 Feb 2022 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —20,547 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.